Responses
Immune cell therapies and immune cell engineering
Original research
WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma
Compose a Response to This Article
Other responses
No responses have been published for this article.